跳至主要内容
临床试验/CTRI/2025/07/090336
CTRI/2025/07/090336尚未招募2/3 期

A Randomised comparative clinical trial to study the efficacy of Asana Churna and Guduchyadi Churna in the management of Sthaulya [Overweight] in children of age group10 to 16 Years.

PDEAs College of Ayurved and Research Centre Nigdi Pune1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2025年8月5日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
64
试验地点
1
主要终点
Assessment Criteria :

研究概览

简要总结

In modern science, drugs are used for obesity which reduces absorption of

food or causes suppression of appetite but all these have their limitations due to their Side

effects.

This treatment may generate economic burden on family. So, by following the Ayurveda

Principles for healthy lifestyle and with effective treatment We can beat the obesity and

prevalence can be reduced.

Here, Asana churna is a trial drug chosen from sahastrayog. Asan is a tikta ,

kashaya rasatmak , katu vipaki and ushna virya dravya . With the help of laghu, rooksha

guna and it’s ras, virya ,vipaka Asan helps to reduce Kapha and medodushti.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
10.00 Year(s) 至 16.00 Year(s)(—)
性别
All

入选标准

  • Children diagnosed with Sthaulya having two or more Clinical features of Sthaulya as Kshudhadhikya, Shariragaurava, Swedabadh, Daurgandha, Daurbalya ,Trushnadhikya.
  • Patients having BMI
  • Weight more than 86 to 95 percentile of that age [i.e. Overweight].

排除标准

  • Overweight due to known case of endocrine disorder like Hypothyroidism, inborn error of metabolism.
  • Known case of Congenital anomalies, known case of any acute infection, and major renal diseases.

结局指标

主要结局

Assessment Criteria :

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Subjective Parameter –

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Kshudhadhikya [Increased Appetite]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Shariragaurava [Heaviness in the body]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Swedabadh [Excessive Sweating]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Daurgandha [Body Odour]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Daurbalya [Generalized Weakness]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Trushnadhikya [ Excessive thirst]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

Objective Parameter –

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Body weight [Kg – in percentile]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• BMI [Kg/M 2]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Waist Circumference [cm]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Hip Circumference [cm]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Waist / Hip circumference ratio

时间窗: 60 days with follow up on 7th 15th 45th 60th day

• Mid arm circumference [cm]

时间窗: 60 days with follow up on 7th 15th 45th 60th day

次要结局

  • To observe and compare the adverse effect if any during treatment.(60 days with follow up on 7th 15th 45th 60th day)

研究者

发起方
PDEAs College of Ayurved and Research Centre Nigdi Pune
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Aishwarya Khedkar

PDEAs College of Ayurved and Research Centre Nigdi Pune

研究点 (1)

Loading locations...

相似试验